Updated:
M4 Capital
M4 Capital was established in 2015 by Prof. Dr. Reinhard Meier. The firm manages capital generated from his prior healthcare exits. It operates as a single...
M4 Capital
M4 Capital was established in 2015 by Prof. Dr. Reinhard Meier. The firm manages capital generated from his prior healthcare exits. It operates as a single family office with a stated focus on long-term holdings rather than short-term trading. The office deploys into venture capital, private equity and real estate. Confirmed holdings include Cambrian Biopharma and flair.hr and multiple European health-tech platforms. It participates through direct co-investments, SPVs and fund commitments. Activity spans Europe and North America, with emphasis on early-stage and growth equity rounds in digital health, climate technology and workflow automation. Team size and total deployment figures are not publicly stated. The firm maintains its headquarters in Munich and works with co-investor Soleria Capital on select technology and design deals. No additional offices or philanthropic vehicles are disclosed in available materials. M4 Capital separates its health-tech mandate into the parallel fund YZR Capital. This structure allows dedicated sourcing and governance for biotech and care-delivery investments while the parent office retains real-estate and broader private-equity exposure.
General information
Firm type
Single Family Office
Year founded
2015
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Thomas-Wimmer-Ring 9, 80539 Munich, Germany
Principals
Prof. Dr. Reinhard Meier
Founder and Managing Partner
Tom Solo
Managing Partner
Markus Feuerecker
Business Partner
Sector focus
Frequently asked questions
Who runs investment decisions at M4 Capital?
Prof. Dr. Reinhard Meier serves as Founder and Managing Partner. Tom Solo acts as Managing Partner. Markus Feuerecker participates as a business partner on select mandates.
How does M4 Capital source proprietary deal flow?
The firm draws on Prof. Dr. Reinhard Meier’s network in European healthcare and technology. It also co-invests alongside Soleria Capital on technology and design opportunities.
Is M4 Capital structured as a single family office or does it operate more like a venture firm?
It is organized as a single family office. Health-tech activities have been placed into the separate vehicle YZR Capital while the parent retains real-estate and private-equity exposure.
Does M4 Capital participate in fund commitments or only direct deals?
The firm uses both approaches. It makes direct co-investments and SPVs while also committing to external venture and private-equity funds.
What investment stages does M4 Capital typically target?
Activity covers early stage through late stage. Portfolio examples include seed and Series A health-tech companies as well as growth equity and real-estate platforms.
Where does the underlying wealth come from?
Wealth originates from Prof. Dr. Reinhard Meier’s sale of TeleClinic and additional healthcare ventures.
What is M4 Capital’s known posture on co-investments alongside external GPs?
The firm regularly co-invests with partners such as Soleria Capital on technology and design startups.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: